Clinton J. Lott

FDA investigator

Appears on 10 documents from 2021 to 2024, most often at sites in India. Most often cites production record review (21 CFR 211.192).

10
Documents on file
4.0
Observations per 483
2021
First seen
2024
Most recent

What they cite most

From 40 observations

Activity by year

2021: 2, 2022: 3, 2023: 1, 2024: 4

Where

India 3 · Tennessee 3 · Florida 2 · Dominican Republic 1 · Texas 1

Is Clinton J. Lott coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

10 documents, newest first
FirmOpen
483 OneSource Specialty Pharma LimitedNov 22, 2024 · Bengaluru, India
483 BIOLOGICAL E. LIMITEDNov 12, 2024 · Medchal, India
483 Alcon Research LLCAug 30, 2024 · Fort Worth, Texas
483 Acharya ChemicalsMar 15, 2024 · Thane, India
483 Laboratorios Dr. Collado, S.A.Apr 21, 2023 · Santo Domingo, Dominican Republic
483 Consumer Product Partners, LLCNov 7, 2022 · Smyrna, Tennessee
483 Midlab IncorporatedAug 5, 2022 · Athens, Tennessee

About this profile

What does Clinton J. Lott inspect?

Clinton J. Lott appears on 10 documents on file covering 10 sites, most often in India.

What do they cite most often?

21 CFR 211.192 (production record review), followed by 21 CFR 211.113 and 21 CFR 211.22.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Clinton J. Lott is dated Nov 22, 2024.